Evidence map›Paper›PMID 24348269›Full record

ArticlePLoS genetics2013

Sumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval development.

Jordan D Ward, Nagagireesh Bojanala, Teresita Bernal, Kaveh Ashrafi, Masako Asahina, Keith R Yamamoto

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. The Binding Landscape of an Essential Nuclear Hormone Receptor inbioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Rapid Degradation ofG3 (Bethesda, Md.) · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jordan D WardDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
Nagagireesh BojanalaInstitute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic.
Teresita BernalDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
Kaveh AshrafiDepartment of Physiology, University of California San Francisco, San Francisco, California, United States of America.
Masako AsahinaDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America ; Institute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic.
Keith R YamamotoDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USInstitute of Parasitology · CZ

Funding

GENE REGULATION BY STEROID RECEPTOR PROTEINSR01CA020535 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAMAMOTO, KEITH ROBERT · 1985 to 2018
$8.9M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
A platform for rapid characterization of metabolic disrupters in whole animalsR21ES021412 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, BAINTON, ROLAND J · 2012 to 2013
$420k
GENE REGULATION BY STEROID RECEPTOR PROTEINSR37CA020535 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI YAMAMOTO, KEITH ROBERT · 1990 to 1998
–
CIHR #234765NCI NIH HHS CA20535NCI NIH HHS R01 CA020535NCI NIH HHS R37 CA020535NIEHS NIH HHS ES021412-01NIEHS NIH HHS R21 ES021412NIH HHS P40 OD010440
6 · The paper itself

Abstract

Individual metazoan transcription factors (TFs) regulate distinct sets of genes depending on cell type and developmental or physiological context. The precise mechanisms by which regulatory information from ligands, genomic sequence elements, co-factors, and post-translational modifications are integrated by TFs remain challenging questions. Here, we examine how a single regulatory input, sumoylation, differentially modulates the activity of a conserved C. elegans nuclear hormone receptor, NHR-25, in different cell types. Through a combination of yeast two-hybrid analysis and in vitro biochemistry we identified the single C. elegans SUMO (SMO-1) as an NHR-25 interacting protein, and showed that NHR-25 is sumoylated on at least four lysines. Some of the sumoylation acceptor sites are in common with those of the NHR-25 mammalian orthologs SF-1 and LRH-1, demonstrating that sumoylation has been strongly conserved within the NR5A family. We showed that NHR-25 bound canonical SF-1 binding sequences to regulate transcription, and that NHR-25 activity was enhanced in vivo upon loss of sumoylation. Knockdown of smo-1 mimicked NHR-25 overexpression with respect to maintenance of the 3° cell fate in vulval precursor cells (VPCs) during development. Importantly, however, overexpression of unsumoylatable alleles of NHR-25 revealed that NHR-25 sumoylation is critical for maintaining 3° cell fate. Moreover, SUMO also conferred formation of a developmental time-dependent NHR-25 concentration gradient across the VPCs. That is, accumulation of GFP-tagged NHR-25 was uniform across VPCs at the beginning of development, but as cells began dividing, a smo-1-dependent NHR-25 gradient formed with highest levels in 1° fated VPCs, intermediate levels in 2° fated VPCs, and low levels in 3° fated VPCs. We conclude that sumoylation operates at multiple levels to affect NHR-25 activity in a highly coordinated spatial and temporal manner.

Indexed as

SumoylationAmino Acid SequenceAnimalsCaenorhabditis elegansCell DifferentiationDNA-Binding ProteinsFemaleGene Expression Regulation, DevelopmentalProtein Interaction MapsSignal TransductionSUMO-1 ProteinTranscription FactorsVulvaDNA-Binding Proteinsnuclear hormone receptor NHR-25, C elegansSUMO-1 ProteinTranscription Factors

Identifiers

PMID24348269
PMCPMC3861103
OpenAlexW2007786531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.